Jump to main content

Keep learning about Alpha‑1

Sign up if you’re interested in receiving additional information about Alpha‑1, including management, resources, and news about this rare disorder.


Diagnosis status*:
Status of Alpha‑1 management plan*:

By providing your information, you consent to receiving marketing and promotional communications related to Alpha‑1 antitrypsin deficiency (Alpha‑1), and Alpha‑1 products and other information from Takeda. You hereby give consent to Takeda, its affiliates and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such time as you opt out of communications from Takeda. We encourage you to read our privacy notice by clicking this link: review Privacy Notice.

Back to Top